CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $17,000 | -46.9% | 3,390 | +34.4% | 0.00% | – |
Q4 2020 | $32,000 | +28.0% | 2,522 | 0.0% | 0.00% | – |
Q3 2020 | $25,000 | -30.6% | 2,522 | -30.5% | 0.00% | – |
Q2 2020 | $36,000 | +24.1% | 3,631 | +10.1% | 0.00% | – |
Q1 2020 | $29,000 | -12.1% | 3,299 | -6.7% | 0.00% | – |
Q4 2019 | $33,000 | +57.1% | 3,535 | 0.0% | 0.00% | – |
Q3 2019 | $21,000 | -50.0% | 3,535 | 0.0% | 0.00% | – |
Q2 2019 | $42,000 | -2.3% | 3,535 | 0.0% | 0.00% | – |
Q1 2019 | $43,000 | +7.5% | 3,535 | +11.3% | 0.00% | – |
Q4 2018 | $40,000 | -14.9% | 3,177 | 0.0% | 0.00% | – |
Q3 2018 | $47,000 | -11.3% | 3,177 | 0.0% | 0.00% | – |
Q2 2018 | $53,000 | -27.4% | 3,177 | +0.2% | 0.00% | – |
Q1 2018 | $73,000 | -38.1% | 3,172 | -30.3% | 0.00% | – |
Q4 2017 | $118,000 | +49.4% | 4,552 | -15.9% | 0.00% | – |
Q3 2017 | $79,000 | +27.4% | 5,414 | +22.2% | 0.00% | – |
Q2 2017 | $62,000 | -16.2% | 4,429 | 0.0% | 0.00% | – |
Q1 2017 | $74,000 | +39.6% | 4,429 | -14.3% | 0.00% | – |
Q4 2016 | $53,000 | +152.4% | 5,168 | +142.1% | 0.00% | – |
Q3 2016 | $21,000 | -12.5% | 2,135 | 0.0% | 0.00% | – |
Q2 2016 | $24,000 | -17.2% | 2,135 | 0.0% | 0.00% | – |
Q1 2016 | $29,000 | – | 2,135 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |